NO152837C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive allylaminderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive allylaminderivater.

Info

Publication number
NO152837C
NO152837C NO821799A NO821799A NO152837C NO 152837 C NO152837 C NO 152837C NO 821799 A NO821799 A NO 821799A NO 821799 A NO821799 A NO 821799A NO 152837 C NO152837 C NO 152837C
Authority
NO
Norway
Prior art keywords
sub
integer
hydrogen
formula
phenyl
Prior art date
Application number
NO821799A
Other languages
English (en)
Norwegian (no)
Other versions
NO152837B (no
NO821799L (no
Inventor
Philippe Bey
Original Assignee
Merrell Toraude & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude & Co filed Critical Merrell Toraude & Co
Publication of NO821799L publication Critical patent/NO821799L/no
Publication of NO152837B publication Critical patent/NO152837B/no
Publication of NO152837C publication Critical patent/NO152837C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483—Monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/486—Polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Treatment Of Sludge (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO821799A 1981-06-01 1982-05-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive allylaminderivater. NO152837C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/268,555 US4454158A (en) 1981-06-01 1981-06-01 Allyl amine MAO inhibitors

Publications (3)

Publication Number Publication Date
NO821799L NO821799L (no) 1982-12-02
NO152837B NO152837B (no) 1985-08-19
NO152837C true NO152837C (no) 1985-11-27

Family

ID=23023513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821799A NO152837C (no) 1981-06-01 1982-05-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive allylaminderivater.

Country Status (18)

Country Link
US (1) US4454158A (ja)
EP (1) EP0067105B1 (ja)
JP (1) JPS5823649A (ja)
KR (1) KR890002756B1 (ja)
AT (1) ATE29875T1 (ja)
AU (2) AU550607B2 (ja)
CA (2) CA1187500A (ja)
DE (1) DE3277371D1 (ja)
DK (1) DK244282A (ja)
ES (4) ES8402810A1 (ja)
GB (2) GB2100255B (ja)
GR (1) GR78033B (ja)
IE (1) IE53456B1 (ja)
IL (2) IL65808A (ja)
MX (1) MX9202950A (ja)
NO (1) NO152837C (ja)
NZ (1) NZ200644A (ja)
ZA (1) ZA823633B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
NZ214697A (en) * 1984-12-31 1988-10-28 Merrell Dow Pharma B-methylene-2- and 3-furanethanamine and pharmaceutical compositions
NZ214698A (en) * 1984-12-31 1988-08-30 Merrell Dow Pharma Thiophene derivatives and pharmaceutical compositions containing such
US4703058A (en) * 1984-12-31 1987-10-27 Merrell Dow Pharmaceuticals Inc. β-methylene furanethanamines and use as anti-hypertensive agents
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
ES2033233T3 (es) * 1985-12-05 1993-03-16 Merrell Dow Pharmaceuticals Inc. Un procedimiento para preparar una fluoralilamina.
US4822812A (en) * 1987-05-21 1989-04-18 Merrell Dow Pharmaceuticals Inc. β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
ZA884183B (en) * 1987-06-16 1989-02-22 Merrell Dow Pharma (e)-2-(p-fluorophenethyl)-3-fluoroallylamine
US5182297A (en) * 1988-02-25 1993-01-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
CA1338647C (en) * 1988-02-25 1996-10-15 Michael G. Palfreyman Inhibitors of lysyl oxidase
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4981868A (en) * 1989-07-25 1991-01-01 Merrell Dow Pharmaceutical Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins
JP3273141B2 (ja) * 1995-03-02 2002-04-08 アール． ピー． シェーラー リミテッド モノアミンオキシダーゼｂインヒビターからなる医薬組成物
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP2046794A1 (de) * 2006-07-13 2009-04-15 Basf Se Fungizide azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
WO2009055002A1 (en) * 2007-10-24 2009-04-30 La Jolla Pharmaceutical Company Combined inhibitors of cyclooxygenase and semicarbazide-sensitive amine oxidase (ssao) (vascular adhesion protein, vap-1)
JP2011504485A (ja) 2007-11-21 2011-02-10 ファーマクシス リミテッド Ｓｓａｏ／ｖａｐ−１のハロアリルアミン阻害剤およびその用途
AU2013255103B2 (en) 2012-05-02 2016-09-29 Pharmaxis Ltd. Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
WO2015087094A1 (en) * 2013-12-10 2015-06-18 Semmelweis Egyetem New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases
CA3105599A1 (en) 2018-08-03 2020-02-06 Pharmaxis Ltd. Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2343038A1 (de) * 1973-08-25 1975-03-06 Hoechst Ag 2,3-diaryl-3-halogenallylamine und verfahren zu ihrer herstellung
SE7809127L (sv) * 1978-08-30 1980-03-01 Claesson Alf Allenaminer

Also Published As

Publication number Publication date
GB2100255B (en) 1985-10-23
EP0067105B1 (en) 1987-09-23
IL75829A0 (en) 1985-11-29
US4454158A (en) 1984-06-12
GR78033B (ja) 1984-09-26
ES8507461A1 (es) 1985-10-01
MX9202950A (es) 1992-07-01
ATE29875T1 (de) 1987-10-15
EP0067105A2 (en) 1982-12-15
US4454158B1 (ja) 1992-12-22
GB2152039A (en) 1985-07-31
IE821246L (en) 1982-12-01
AU8423882A (en) 1983-02-03
ZA823633B (en) 1983-03-30
DK244282A (da) 1982-12-02
IL65808A (en) 1986-12-31
ES8503639A1 (es) 1985-04-16
GB8428858D0 (en) 1984-12-27
ES523873A0 (es) 1985-10-01
IE53456B1 (en) 1988-11-23
NO152837B (no) 1985-08-19
IL65808A0 (en) 1982-08-31
ES8503638A1 (es) 1985-04-16
NO821799L (no) 1982-12-02
ES512699A0 (es) 1984-03-01
AU550607B2 (en) 1986-03-27
CA1187500A (en) 1985-05-21
JPH0422898B2 (ja) 1992-04-20
ES8402810A1 (es) 1984-03-01
DE3277371D1 (en) 1987-10-29
EP0067105A3 (en) 1984-02-22
GB2152039B (en) 1986-04-30
JPS5823649A (ja) 1983-02-12
AU5180586A (en) 1986-06-12
KR890002756B1 (ko) 1989-07-27
AU576281B2 (en) 1988-08-18
KR830010044A (ko) 1983-12-24
GB2100255A (en) 1982-12-22
ES523875A0 (es) 1985-04-16
CA1204759A (en) 1986-05-20
ES523874A0 (es) 1985-04-16
NZ200644A (en) 1986-06-11

Similar Documents

Publication Publication Date Title
US4454158B1 (ja)
NO812311L (no) Bronchospasmolytisk virksomme forbindelser og fremgangsmaate for deres fremstilling
KR900007406A (ko) 리실 옥시마제의 억제제
NO921719L (no) Fosfono/biaryl-substituerte dipeptidderivater
ATE215925T1 (de) Aryl- oder heteroaryl-substituierte 3,4- dihydroanthracene sowie aryl- oder heteroaryl- substituierte benzo(1,2g)-chrom-3-en-, benzo(1, 2g)-thiochrom-3-en- und benzo(1,2g)-1,2- dihydrochinolin-derivate mit retinoid antagonistischer oder invers antagonistischer aktivität
NZ301692A (en) Use of a compound which is both a beta adrenoreceptor antagonist and a alpha-1 adrenoreceptor antagonist especially carvedilol to treat congestive heart failure either on its own or with an angiotensin converting enzyme inhibitor, diuretic and/or cardiac glycoside
ES2000842A6 (es) Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina
ES2115163T3 (es) Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis.
CA2312935A1 (en) Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
ES482156A1 (es) Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
RU94044454A (ru) Ингибитор аутоимунных заболеваний
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
ES477784A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino-imidazolidinas sustituidas.
KR890012641A (ko) 리실 옥시다제의 억제제
GB1476906A (en) Aromatic ethers and thioethers
EP0218195A3 (en) Bis(dibenzo[b,d]pyranyloxy)propanes
DK60793D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
GB1503962A (en) 2-(halo-vinyl(or ethynyl))-5-nitro furans and their use as microbiocides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2000